|4/AJan 19, 5:54 PM ET

LEE WILLIS C 4/A

4/A · Emmaus Life Sciences, Inc. · Filed Jan 19, 2023

Insider Transaction Report

Form 4/AAmended
Period: 2023-01-12
LEE WILLIS C
DirectorVice Chairman & COO
Transactions
  • Award

    Options

    2023-01-12$4.50/sh+500,000$2,250,000500,000 total
    Exercise: $4.50Exp: 2033-01-11Common Stock (500,000 underlying)
Footnotes (1)
  • [F1]The options vest as to one-third of the option shares on the 12-month anniversary of the grant date and as to the remaining two-thirds of the option shares in 24 equal monthly installments as of the end of each month after such anniversary.

Documents

1 file
  • 4
    doc4a.xml

    FORM 4/A SUBMISSION